PRESS RELEASE published on 02/05/2026 at 15:24, 15 days 21 hours ago Information sur les droits de vote et les actions au 31 janvier 2026 Publication des informations sur le nombre total d'actions et de droits de vote d'Ubisoft Group au 31 janvier 2026 conformément à l'AMF Euronext Paris Droits De Vote Capital Social AMF Ubisoft Group
PRESS RELEASE published on 02/05/2026 at 15:15, 15 days 22 hours ago FIS SUCCESSFULLY COMPLETES €770 MILLION BOND ISSUANCE FIS successfully completes €770 million bond issuance, attracting strong interest from institutional investors and significantly oversubscribed, improving liquidity and financial flexibility Pharmaceutical Industry Institutional Investors Bond Issuance Financial Flexibility FIS
PRESS RELEASE published on 02/05/2026 at 15:13, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses 5.07% stake in JTC plc. Form 8.3 filing according to Rule 8.3 of the Takeover Code Form 8.3 Takeover Code Vanguard Group Stake Disclosure JTC Plc
PRESS RELEASE published on 02/05/2026 at 15:12, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Glencore plc The Vanguard Group, Inc. discloses 4.89% ownership in Glencore plc as of 04-Feb-2026. Additional disclosures include interests in Rio Tinto plc and Rio Tinto Limited The Vanguard Group Ownership Disclosure Financial Disclosure Glencore Plc Rio Tinto Plc
PRESS RELEASE published on 02/05/2026 at 15:12, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses a 5.94% ownership in Avadel Pharmaceuticals plc. Form 8.3 filed with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Ownership Disclosure Avadel Pharmaceuticals Plc
PRESS RELEASE published on 02/05/2026 at 15:11, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Beazley plc The Vanguard Group, Inc. discloses a 5.02% interest in Beazley plc's 5p ordinary securities. Details of recent dealings provided Securities Vanguard Group Dealings Interest Beazley Plc
PRESS RELEASE published on 02/05/2026 at 15:10, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Spire Healthcare Group plc The Vanguard Group, Inc. discloses a 3.58% interest in Spire Healthcare Group plc's relevant securities. Purchase and sale transactions reported The Vanguard Group Spire Healthcare Interest Disclosure Purchase Transactions Sale Transactions
PRESS RELEASE published on 02/05/2026 at 15:10, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses a 4.93% interest in Just Group plc's 10p ordinary securities. Dealings include sale of 8,192 securities at 2.16 GBP per unit Securities Disclosure Vanguard Group Dealings Just Group Plc
PRESS RELEASE published on 02/05/2026 at 15:10, 15 days 22 hours ago Electric Metals (USA) Limited Announces Change of Auditor Electric Metals appoints PwC as new auditor, ending relationship with Baker Tilly. Company's focus on domestic manganese supply chain. Detailed project overview provided Auditor Change Electric Metals North Star Project PwC Manganese Supply Chain
PRESS RELEASE published on 02/05/2026 at 15:09, 15 days 22 hours ago Form 8.3 - The Vanguard Group, Inc.: Picton Property Income Limited The Vanguard Group, Inc. discloses a 5.25% ownership in Picton Property Income Limited through Form 8.3 as of 04 February 2026 Form 8.3 Vanguard Group Ownership Disclosure Picton Property Income Cash Offer
Published on 02/21/2026 at 00:45, 12 hours 34 minutes ago Bocana Resources Corp. Extends Letter of Intent on Arizona Mining Claims for Additional Bulk Testing and Assay Review
Published on 02/21/2026 at 00:30, 12 hours 49 minutes ago Redwood AI Corp. Announces Engagement for IR Services
Published on 02/20/2026 at 23:00, 14 hours 19 minutes ago Infinico Metals Corp. Announces Effective Date for 15-for-1 Common Share Consolidation
Published on 02/20/2026 at 22:17, 15 hours 2 minutes ago Organto Foods Completes Warrant Exercise Incentive Program
Published on 02/21/2026 at 12:00, 1 hour 19 minutes ago Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Published on 02/21/2026 at 12:00, 1 hour 19 minutes ago Abivax présente, au Congrès de l’ECCO 2026, les premières preuves d’une activité antifibrotique d'obefazimod, ainsi que de nouvelles analyses de son efficacité et de sécurité dans les MICI
Published on 02/20/2026 at 18:36, 18 hours 42 minutes ago EQS-Adhoc: innoscripta SE: Management Board Proposes Dividend of EUR 4.00 per Share
Published on 02/20/2026 at 18:31, 18 hours 48 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 02/20/2026 at 19:29, 17 hours 50 minutes ago SFPI GROUP: Liquidity agreement report S2 2025
Published on 02/20/2026 at 19:29, 17 hours 50 minutes ago SFPI GROUP: bilan du contrat de liquidité S2 S025
Published on 02/20/2026 at 18:00, 19 hours 19 minutes ago TERACT - Termination of liquidity agreement
Published on 02/20/2026 at 18:00, 19 hours 19 minutes ago TERACT - Résiliation du contrat de liquidité
